" class="no-js "lang="en-US"> Ultromics - Medtech Alert
Saturday, August 02, 2025
Ultromics | Pharmtech Focus

Ultromics

About Ultromics

Ultromics

Ultromics is a global health technology company which provides autonomous echocardiography analysis through innovative AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease.

Our cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. Our aim is to save clinicians time and allow them to confidently make diagnostic decisions. We are helping healthcare providers streamline care, increase productivity and improve patient outcomes whilst also allowing them to make valuable resource and cost savings.

Related Story

Ultromics Granted FDA Breakthrough Device Designation for AI-Enhanced Cardiac Amyloidosis Detection

April 27 2023

Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been […]

Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands

November 9 2021

Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]

Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment

August 17 2021

Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]